Due to their usefulness for cancer therapy and/or diagnosis, as well as their association with chemotherapy response, efforts should be undertaken to develop and test inhibitors that can be evaluated in clinical trials, such as the LAT1 inhibitor JHP203, hopefully enabling the improvement of cancer prognosis. The gene discussed is SLC7A5; the disease is cancer.